Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B J Foster

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Cancer Treatment Reviews|December 1, 1986
Hexamethylmelamine: a critical review of an active drugB J Foster, B J Harding, B Leyland-Jones, et al.
Cancer Treatment Reviews|September 1, 1985
Results of NCI-sponsored phase I trials with carboplatinB J Foster, K Clagett-Carr, B Leyland-Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1995
Pharmacokinetics of 9-methoxy-N,N-dimethyl-5-nitropyrazolo [3,4, 5-kl]acridine-2(6H)-propanamine (PZA, PD 115934, NSC 366140) in mice: guidelines for early clinical trials1B J Foster, R A Wiegand, P M LoRusso, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
The pharmacokinetics and toxicity of the anthrapyrazole anti-cancer drug CI-941 in the mouse: a guide for rational dose escalation in patientsM A Graham, D R Newell, B J Foster, et al.
Cancer Treatment Reports|November 1, 1985
Hypoglycemia: not an important side effect of mitoguazoneB J Foster, K Clagett-Carr, P J O'Dwyer, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 12, 2011
Change in mortality risk over time in young kidney transplant recipientsB J Foster, M Dahhou, X Zhang, et al.
Cancer Treatment Reports|August 1, 1986
Role of hexamethylmelamine in the treatment of ovarian cancer: where is the needle in the haystack?B J Foster, K Clagett-Carr, S Marsoni, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 21, 2015
High Risk of Graft Failure in Emerging Adult Heart Transplant RecipientsB J Foster, M Dahhou, X Zhang, et al.
Investigational New Drugs|June 9, 1999
Cryptophycin 1 cellular levels and effects in vitro using L1210 cellsB J Foster, M Fortuna, J Media, et al.
Investigational New Drugs|January 1, 1997
Preclinical pharmacokinetic, antitumor and toxicity studies with CI-994 (correction of CL-994) (N-acetyldinaline)B J Foster, L Jones, R Wiegand, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Cancer Treatment Reviews|December 1, 1986
Hexamethylmelamine: a critical review of an active drugB J Foster, B J Harding, B Leyland-Jones, et al.
Cancer Treatment Reviews|September 1, 1985
Results of NCI-sponsored phase I trials with carboplatinB J Foster, K Clagett-Carr, B Leyland-Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1995
Pharmacokinetics of 9-methoxy-N,N-dimethyl-5-nitropyrazolo [3,4, 5-kl]acridine-2(6H)-propanamine (PZA, PD 115934, NSC 366140) in mice: guidelines for early clinical trials1B J Foster, R A Wiegand, P M LoRusso, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
The pharmacokinetics and toxicity of the anthrapyrazole anti-cancer drug CI-941 in the mouse: a guide for rational dose escalation in patientsM A Graham, D R Newell, B J Foster, et al.
Cancer Treatment Reports|November 1, 1985
Hypoglycemia: not an important side effect of mitoguazoneB J Foster, K Clagett-Carr, P J O'Dwyer, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 12, 2011
Change in mortality risk over time in young kidney transplant recipientsB J Foster, M Dahhou, X Zhang, et al.
Cancer Treatment Reports|August 1, 1986
Role of hexamethylmelamine in the treatment of ovarian cancer: where is the needle in the haystack?B J Foster, K Clagett-Carr, S Marsoni, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 21, 2015
High Risk of Graft Failure in Emerging Adult Heart Transplant RecipientsB J Foster, M Dahhou, X Zhang, et al.
Investigational New Drugs|June 9, 1999
Cryptophycin 1 cellular levels and effects in vitro using L1210 cellsB J Foster, M Fortuna, J Media, et al.
Investigational New Drugs|January 1, 1997
Preclinical pharmacokinetic, antitumor and toxicity studies with CI-994 (correction of CL-994) (N-acetyldinaline)B J Foster, L Jones, R Wiegand, et al.
Pageof 4